Clinical Research Directory
Browse clinical research sites, groups, and studies.
Evaluation of 18F-TFB PET/CT Scan in Patients With Differentiated Thyroid Cancer
Sponsor: Mayo Clinic
Summary
This phase II study evaluates F-18 tetrafluoroborate (18F-TFB) PET/CT scan in patients with differentiated thyroid cancer. Diagnostic imaging is necessary for planning treatment, monitoring therapy response, and identifying sites of recurrent or metastatic disease in differentiated thyroid cancer. 18F-TFB PET/CT may accurately detect recurrent and metastatic thyroid cancer lesions, with the potential to provide information for patient management that is better than the current standard of care imaging practices.
Official title: Evaluation of F-18 Tetrafluoroborate (18F-TFB) PET/CT in Patients With Differentiated Thyroid Cancer
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
24
Start Date
2022-04-22
Completion Date
2028-05-01
Last Updated
2026-02-27
Healthy Volunteers
No
Conditions
Interventions
Computed Tomography
Undergo a PET/CT scan
Fluorine F 18 Tetrafluoroborate
Given IV
Positron Emission Tomography
Undergo a PET/CT scan
Survey Administration
Ancillary studies
Locations (1)
Mayo Clinic in Rochester
Rochester, Minnesota, United States